Alzheimer's Disease Trial, Recruiting NCT06995638 Sponsor: Rutgers, The State University of New Jersey Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Recruiting

NCT06995638
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 60 and 75 years old
  • People who can read, write, and communicate in English well enough to take part
  • People who are willing to follow the study schedule, which includes attending 2 in-person assessment visits, attending one blood test appointment, and taking part in online sessions and an online follow-up assessment

Who may not be able to join:

  • People who score below 26 on a standard memory and thinking test called the Montreal Cognitive Assessment
  • People who have a known history of memory or thinking problems, dementia, stroke, seizures, or other brain or mental health conditions that affect thinking ability
  • People who are currently taking medications that are known to affect memory or thinking
  • People who have vision, hearing, or physical difficulties (such as severe joint, bone, or nerve problems) that would make it hard to use a standard computer
  • People who are already taking part in another research study that could affect the results of this trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sharon Sanz Simon Assistant Professor, Ph.D., Rutgers University

Phone: 973-972-2977

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Rutgers, The State University of New Jersey
Registry
ClinicalTrials.gov
Start date
10 December 2025
Est. completion
1 December 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Changes in the Breakfast Game scores; Transfer to complex executive/attention control measure (Proximal outcome).

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov